Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Renal Denervation Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Renal Denervation Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Renal Denervation Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Renal Denervation Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
4.3. Radiofrequency based
4.3.1. Radiofrequency based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Ultrasound based
4.4.1. Ultrasound based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Micro-Infusion based
4.5.1. Micro-Infusion based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Renal Denervation Market: Regional Estimates & Trend Analysis
5.1. Renal Denervation Market Share, By Region, 2023 & 2030 (USD Million)
5.2. North America
5.2.1. North America Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. U.K.
5.3.2.1. U.K. Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. China Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Japan Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. South Korea
5.4.5.1. South Korea Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Australia
5.4.6.1. Australia Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Thailand Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Argentina Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. UAE
5.6.3.1. UAE Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. South Africa
. South Africa Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait Renal Denervation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Medtronic
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Abbott
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Ablative Solutions, Inc.
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. Mercator MedSystems, Inc.
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Otsuka Medical Devices Co., Ltd.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Boston Scientific Corporation
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. SympleSurgical, Inc.
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Johnson & Johnson Services, Inc.
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives